DBS Group Research

Broker's Calls

DBS maintains 'buy' on Silverlake Axis as order backlog remains strong

Analyst Ling Lee Keng has lowered her TP slightly to 42 cents from 45 cents as order win momentum could be slower in the near term

Broker's Calls

S-REITs at an inflection point, CLSA upgrades sector to 'overweight'

The relative underperformance of interest rate sensitive sectors like S-REITs will start to turn the corner moving forward.

Broker's Calls

Analysts keep 'buy' on Cromwell European REIT, expecting DPU to bottom this year

CEREIT targets to divest EUR400 million in non-strategic assets over the next one to two years.

Broker's Calls

Brokers' Digest: StarHub, UMS Holdings, Genting Singapore

See what the analysts have to say.
DBS keeps 'buy' on BRC Asia despite 1HFY2023 dip, sees improvements to come - THE EDGE SINGAPORE

Broker's Calls

DBS keeps 'buy' on BRC Asia despite 1HFY2023 dip, sees improvements to come

DBS analyst Lee Eun Young has reduced her target price to $1.89 from $2.22 previously.

Broker's Calls

Analysts mixed on OCBC after record 1QFY2023 earnings

The analysts’ target prices range from $12.20 to $17.32 for the bank.
Analysts keep 'buy' for ComfortDelGro but lower TP amid slower recovery - THE EDGE SINGAPORE

Broker's Calls

Analysts keep 'buy' for ComfortDelGro but lower TP amid slower recovery

Analysts say CDG’s 1QFY2023’s net profit was below their expectations, but are showing q-o-q improvements.
Potential rescue by acquirer Mirae could dilute Manulife US REIT's DPU; DBS halves TP to 24 US cents - THE EDGE SINGAPORE

Broker's Calls

Potential rescue by acquirer Mirae could dilute Manulife US REIT's DPU; DBS halves TP to 24 US cents

A US$175 million ($236.09 million) capital injection could be the lifebuoy Manulife US REIT (MUST) needs, say DBS's analysts.
APAC Realty fails to to meet DBS's revenue expectations, TP lowered to 57 cents - THE EDGE SINGAPORE

Broker's Calls

APAC Realty fails to to meet DBS's revenue expectations, TP lowered to 57 cents

APAC Realty 1QFY2023 ended in March 31 revenue was 29% down y-o-y at $121.4 mil, and net earnings plunged 67% y-o-y to $3 mil.

Broker's Calls

DBS maintains 'buy' rating for CLINT, whose project pipeline shows 'insatiable' growth potential

The DBS analysts have lowered their target price to $1.45 from $1.50 previously.
×